Datamatics Global Services has entered into a collaboration with SBI Life Insurance to transform underwriting operations through Agentic AI-powered automation, marking a significant step in the adoption of artificial intelligence in the insurance sector.
According to the company, SBI Life has implemented Datamatics’ TruAI Underwriting solution, which is designed to help underwriters manage complex medical underwriting cases with improved speed, consistency and decision support. The initiative aims to streamline underwriting processes that traditionally rely on extensive manual reviews of medical histories, laboratory reports and multiple risk indicators.
The TruAI Underwriting platform ingests and analyses documents including medical reports, declarations and laboratory results to identify critical medical parameters and potential risk indicators. It also generates consolidated digital case summaries and provides intelligent decision support based on underwriting rules and historical outcomes.
Datamatics said the system incorporates self-learning capabilities that continuously enhance risk evaluation over time. However, the company noted that final decision-making authority will remain with human underwriters to ensure governance, accountability and regulatory compliance.
The partnership is expected to improve decision-making, operational efficiency and customer experience for SBI Life while helping accelerate underwriting processes.
Commenting on the development, Rahul Kanodia, Vice Chairman and CEO of Datamatics, said the company has been making strategic investments in AI and Agentic AI solutions to solve complex enterprise problems. He added that intelligent AI agents can help transform insurance underwriting and significantly reduce operational costs.
The collaboration comes as financial services and insurance companies increasingly look at AI-based technologies to automate workflows and improve productivity across critical business functions.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice.